continuing or adding il-2 in patients treated with antiretroviral therapy (actg protocol a5051, a rollover trial of actg protocol a328)抗逆转录病毒疗法患者持续或添加- 2(a5051代理协议,代理协议a328翻转试验).pdfVIP

Bosch et al. AIDS Research and Therapy 2010, 7:30 /content/7/1/30 RESEARCH Open Access Continuing or adding IL-2 in patients treated with antiretroviral therapy (ACTG Protocol A5051, a rollover trial of ACTG Protocol A328) 1* 2 3 1 4 5 Ronald J Bosch , Richard B Pollard , Alan Landay , Evgenia Aga , Lawrence Fox , Ronald Mitsuyasu Abstract Background: Effectiv